TGF-β in tumour microenvironment may limit the synthesis of pro-inflammatory immune factors such as TNF-α, IFN-γ and IL-12, while promoting the release of anti-inflammatory factors such as IL-10 [54,55]. The gene discussed is IFNG; the disease is neoplasm.